Lobbying

Scpharmaceuticals's latest lobbying report covers Q1 2026, at $12.5K. The four quarters Q4 2025–Q3 2026 total $25K. Its first report covers Q4 2023; the issues it reports most are Health Issues and Medicare/Medicaid.

Scpharmaceuticals

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$25K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2023
The first quarter a report named it

Lobbying by quarter

Scpharmaceuticals lobbying by quarter
Scpharmaceuticals lobbying by quarter
QuarterAmountReports
Q4 2023$12.5K1
Q1 2024$12.5K1
Q2 2024$12.5K1
Q3 2024$12.5K1
Q4 2024$12.5K1
Q1 2025$12.5K1
Q2 2025$12.5K1
Q3 2025$12.5K1
Q4 2025$12.5K1
Q1 2026$12.5K1
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$62.5K · 10 reports
  • Medicare and Medicaid$62.5K · 10 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE10 reports

Firms it paid

Firm
Jeffrey J. Kimbell & Associates$125K10 quarters

Former officials lobbying for it

Former position
BRETT MEEKSDeputy Health Policy Director, Senate Committee on Health, Education, Labor and Pensions; Deputy Press Secretary, Office of Senator Lamar AlexanderQ1 2026
JOHN HERZOGHealth Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the PresidentQ1 2026
JOHN R RAYLegislative Assistant, Rep. Mike KellyQ1 2026
KEITH STUDDARDLegislative Director, Rep. Marsha BlackburnQ1 2026
LAURA KEMPERCounsel, Sen. John Cornyn; Deputy Assistant Secretary for Legislation, U.S. Department of Health and Human Services; Counselor to the Secretary, U.S. Department of Health and Human ServicesQ1 2026
KELSEY CARLSONSpecial Assistant, National Security Council; Special Assistant, International Trade Administration, Dept of Commerce; Policy Advisor, Office of the Deputy Chief of Staff, Executive Office of the President; Confidential Assistant, Dept of CommerceQ4 2024

Lobbying reports

Filed by
04/20for Q1Jeffrey J. Kimbell & Associates$12.5K
03/12for Q4 2024Jeffrey J. Kimbell & Associates$12.5K
03/09for Q4 2024Jeffrey J. Kimbell & Associates$12.5K
01/20for Q4 2025Jeffrey J. Kimbell & Associates$12.5K
25/10/20for Q3 2025Jeffrey J. Kimbell & Associates$12.5K
25/09/25for Q4 2024Jeffrey J. Kimbell & Associates$12.5K
25/07/21for Q2 2025Jeffrey J. Kimbell & Associates$12.5K
25/04/15for Q1 2025Jeffrey J. Kimbell & Associates$12.5K
25/01/10for Q4 2024Jeffrey J. Kimbell & Associates$12.5K
24/10/17for Q3 2024Jeffrey J. Kimbell & Associates$12.5K
24/07/15for Q2 2024Jeffrey J. Kimbell & Associates$12.5K
24/04/17for Q1 2024Jeffrey J. Kimbell & Associates$12.5K
24/01/18for Q4 2023Jeffrey J. Kimbell & Associates$12.5K
23/12/14for Q4 2023Jeffrey J. Kimbell & AssociatesUnder $5,000